Stockscreener 앱 받기
40.39
1.69%
0.67
시간 외 거래:
41.00
0.61
+1.51%
전일 마감가:
$39.72
열려 있는:
$39.72
하루 거래량:
2.88M
Relative Volume:
0.99
시가총액:
$5.75B
수익:
-
순이익/손실:
$-284.08M
주가수익비율:
-16.67
EPS:
-2.4234
순현금흐름:
$-234.65M
1주 성능:
+15.60%
1개월 성능:
+166.95%
6개월 성능:
+737.97%
1년 성능:
+319.64%
1일 변동 폭
$39.59
$40.75
1주일 범위
$34.54
$40.75
52주 변동 폭
$3.72
$40.75
코젠트 바이오사이언시스 Stock (COGT) Company Profile
명칭
Cogent Biosciences Inc
전화
617-945-5576
주소
275 WYMAN STREET, WALTHAM
COGT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
40.39 | 6.10B | 0 | -284.08M | -234.65M | -2.4234 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
코젠트 바이오사이언시스 Stock (COGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2025-11-10 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2025-10-16 | 개시 | Stifel | Hold |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-11 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | 개시 | Citigroup | Buy |
| 2023-12-11 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-12-08 | 개시 | JP Morgan | Overweight |
| 2023-04-28 | 개시 | Robert W. Baird | Outperform |
| 2023-03-27 | 재개 | H.C. Wainwright | Buy |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-06-28 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | H.C. Wainwright | Buy |
| 2021-06-09 | 재개 | Jefferies | Buy |
| 2020-12-23 | 개시 | Piper Sandler | Overweight |
| 2020-10-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
코젠트 바이오사이언시스 주식(COGT)의 최신 뉴스
Cogent Biosciences (NASDAQ:COGT) Reaches New 52-Week HighWhat's Next? - MarketBeat
Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans - Yahoo Finance
Top Biotech Stocks To ConsiderNovember 20th - MarketBeat
Biotech Star Cogent Rides High On Breakthrough Trial Hopes - Finimize
Will Cogent Biosciences' (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Finviz
Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Insider Monkey
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cogent Biosciences (NASDAQ:COGT) Sets New 12-Month HighStill a Buy? - MarketBeat
Technical Reactions to COGT Trends in Macro Strategies - news.stocktradersdaily.com
Mintz Advises on Cogent Biosciences Inc.’s Concurrent Public Offerings of $345 Million of Common Stock and $230 Million in Aggregate Principal Amount of 1.625% Convertible Senior Notes Due 2031 - Mintz
Cogent Biosciences stock hits 52-week high at 36.31 USD By Investing.com - Investing.com Canada
COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - Yahoo Finance
Cogent Biosciences stock hits 52-week high at 36.31 USD - Investing.com India
What earnings revisions data tells us about Cogent Biosciences Inc.Earnings Beat & Reliable Trade Execution Plans - newser.com
Cogent Biosciences : COGT Jefferies London 2025 - MarketScreener
Comparing Cogent Biosciences Inc. in custom built stock radarsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Cogent Biosciences (COGT) Price Target Increased by 93.94% to 43.52 - MSN
Cogent Biosciences Completes $230M Convertible Notes Offering - TipRanks
[8-K] Cogent Biosciences, Inc. Reports Material Event | COGT SEC FilingForm 8-K - Stock Titan
Cogent Biosciences, Inc. Bonds — Corporate Bond Rates - TradingView
Will Cogent Biosciences Inc. stock maintain dividend yield2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Profund Advisors LLC Has $145,000 Stock Holdings in Cogent Biosciences, Inc. $COGT - MarketBeat
COGT6232219 Bond Analysis — Key Metrics - TradingView
COGT6232219 Bond Price and Chart — FINRA:COGT6232219 - TradingView
Cogent Biosciences: Soaring On Blowout GIST DataI Expect More Upside (NASDAQ:COGT) - Seeking Alpha
427,342 Shares in Cogent Biosciences, Inc. $COGT Purchased by Candriam S.C.A. - MarketBeat
FY2025 Earnings Estimate for COGT Issued By HC Wainwright - MarketBeat
10 Market Movers That Made Millionaires in a Week - Insider Monkey
Can Cogent Biosciences Inc. stock rebound after recent weaknessWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress - Finviz
Can Cogent Biosciences Inc. stock weather global recessionWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Is Cogent Biosciences Inc. stock a buy before product launchesJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Fox Run Management L.L.C. Trims Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat
How Cogent Biosciences Inc. stock benefits from tech adoptionTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
COGT6232219 Bond Coupon Analysis — Rate & Payments - TradingView
Is Cogent Biosciences Inc a good long term investmentMarket Correction Analysis & Free Dashboard to Track Market Momentum - earlytimes.in
COGENT BIOSCIENCES Earnings Preview: Recent $COGT Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Cogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - The Manila Times
HC Wainwright & Co. Maintains Cogent Biosciences (COGT) Buy Recommendation - Nasdaq
Top Biotech Stocks To Follow TodayNovember 12th - MarketBeat
코젠트 바이오사이언시스 (COGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.16%
자본화:
|
볼륨(24시간):